6 results
The study will investigate the safety and efficacy of emicizumab in patients with hemophilia A with inhibitors against FVIII.
The aim of this study is to validate a clinical VLE prediction score and to develop a VLE computer algorith that could improve detection of early neoplasie in BE patients.
This study will evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of emicizumab in patients of all ages with mild (FVIII level between > 5% and < 40%) or moderate hemophilia A (FVIII level between >= 1% and…
To examine the effectiveness of custom made orthotic insoles by a podiatrist, compared to sham orthotic insoles and education alone in patients with plantar fasciitis in terms of pain, function and recovery.
Study MO41787 will evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of emicizumab administered at 3 mg/kg Q2W for a period of 52 weeks in previously untreated patients (PUPs) and minimally treated patients (MTPs) at study…
Primary objectiveTo determine whether individualized pharmacokinetic (PK)-guided dosing of emicizumab is non-inferior to conventional dosing of emicizumab in the - proportion of patients without treated bleeds (6 months before and after intervention…